Almac Group Recognised with Six Life Science Leader CMO Awards

March 26, 2019

Craigavon, N.I., 26 March 2019Almac Group, the global contract development and manufacturing organisation, is delighted to announce it has won awards in all core categories for 2019 for excellence in Quality, Reliability, Capabilities, Expertise, Compatibility, and Service.

These awards recognise Almac’s global reputation for excellence built over 50 years of client service across the drug development and commercialisation lifecycle and is the organisation’s seventh consecutive year of winning the awards.

The CMO Leadership Awards recognise top performing CMOs, celebrating outstanding companies in drug development and manufacturing, emphasising high standards of quality, integrity and innovation exemplified in their work. The winners were revealed at a ceremony on 20th March at Convene at 237 Park Avenue, New York.

ISR’s Contract Manufacturing Quality Benchmarking research is conducted annually via an online survey. For the 2019 CMO Leadership Awards more than 120 contract manufacturers were evaluated on 23 performance metrics. CMOs must meet the minimum threshold of customer survey responses to be eligible for an award.

Graeme McBurney, President and Managing Director, Almac Pharma Services, commented: “I am both delighted and proud that Almac has been consistently recognised by Life Science Leader at the annual CMO awards. Receiving recognition in all six categories reflects our continued efforts to provide best-in-class services to our global client base and these accreditations are especially meaningful as we have been evaluated by customers we have actually worked with.”

The CMO Leadership Awards are an opportunity to showcase companies with outstanding reliability and service capabilities impacting client’s complete drug development lifecycle.

“The value and importance of the Life Science Leader CMO Awards grows each year. No industry awards are more meaningful than these recognizing the highest level of accomplishment as evaluated by actual customers. An award in any of the categories assessed, including capabilities, compatibility, expertise, quality, reliability and service, adds a clear acknowledgement of the leadership provided by the CMO recipient. Our congratulations to all of this year’s CMO Award winners — you keep the industry on the path to further success.” says Louis Garguilo, Chief Editor and Conference Chair, Outsourced Pharma.

To learn more about Almac’s exceptional culture and commitment to quality, please visit our website:

About Almac Group

A unique culture delivering exceptional solutions

The Almac Group is an established contract development and manufacturing organisation providing an extensive range of integrated services across the drug development lifecycle to the pharmaceutical and biotech sectors globally. Its innovative services range from R&D, biomarker discovery development and commercialisation, API manufacture, formulation development, clinical trial supply, IRT (IVRS/IWRS) through to commercial-scale manufacture.

The international company is a privately owned organisation which has grown organically over the past five decades now employing over 5600 highly skilled personnel across 18 facilities including Europe, the US and Asia.

The company has a global reputation for excellence built over 50 years of client service, delivering expertise right across the drug development lifecycle and offering a tailored solution to each of our clients.

To keep up to date with latest news, follow Almac Group on Twitter and LinkedIn.


Back to news